Company profile for FundaMental Pharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Developer of neuroprotective molecular spacers designed to prevent neurodegeneration in the brain. The company uses peptides and gene therapy approaches for the diagnostics of polymorphisms as well as specializes in a novel class of drugs for combating neurological diseases, providing a pharmacological mode of action for patients suffering from untreatable human neurological conditions.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Im Neuenheimer Feld 582 D-69120 Heidelberg
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2026-02-17/fundamental-pharma-to-showcase-groundbreaking-approach-to-treatment-resistant-depression-at-bio-neuroscience-conference

PHARMIWEB
17 Feb 2026

https://www.globenewswire.com/news-release/2024/04/11/2861355/0/en/FundaMental-Pharma-appoints-Dr-Dirk-Beher-as-Chief-Executive-Officer.html

GLOBENEWSWIRE
11 Apr 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty